Eur Respir J:安第斯高地人群心血管疾病与睡眠呼吸紊乱相关!

2017-06-18 xing.T MedSci原创

在高海拔地区人群中,夜间低氧血症和睡眠呼吸暂停与患者不同的心血管结局相关,过多的红细胞增多症和葡萄糖不耐受分别会导致不同的风险。

高海拔地区睡眠呼吸障碍(SDB)与心脏代谢结局之间的相关性还没有被评估。近日,呼吸疾病领域权威杂志Eur Respir J上发表了一篇研究文章,研究人员秘鲁高地(3825 m)进行了夜间多导睡眠监测。

研究人员采用多变量线性回归模型来评估SDB的指标与血红蛋白、血糖耐受性(糖化血红蛋白A1c(HbA1c))、空腹血糖、稳态模型评估的胰岛素抵抗和β细胞功能(分别为HOMA-IR和HOMA -β)、血压和血脂之间的相关性,同时,调整了年龄、性别、体重指数(BMI)和醒觉时的氧合。

参与者(n=187;91名为男性)年龄(中位数(四分位间距))为52(45-62)岁,并且体重指数为27(24.3-29.5)kg/m2以及在清醒时87%(85-88%)的氧合血红蛋白(动脉血氧饱和度)。在充分调整的模型中,恶化的夜间低氧血症与男性血红蛋白升高相关(P=0.03),独立于醒觉时的氧合和呼吸暂停低通气指数(AHI),而醒觉时的氧合恶化与老年女性血红蛋白升高相关(P=0.02)。与此相反,AHI与HbA1c升高独立相关(P<0.05)。在单变量模型中,夜间低氧血症与较高的HbA1c、HOMA-IR和HOMA -β相关(分别有P<0.001,P=0.02,P=0.04),而AHI与HOMA-IR、收缩压和甘油三酯升高相关(分别有P=0.02,P=0.01,P<0.01)。在完全调整模型中,这些相关性并不显著。

在高海拔地区人群中,夜间低氧血症和睡眠呼吸暂停与患者不同的心血管结局相关,过多的红细胞增多症和葡萄糖不耐受分别会导致不同的风险。

原始出处:

Luu V. Pham,et al. Cardiometabolic correlates of sleep disordered breathing in Andean highlanders. Eur Respir J. http://erj.ersjournals.com/content/49/6/1601705

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1989042, encodeId=369a1989042aa, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Fri Apr 06 22:53:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498208, encodeId=69a71498208c3, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jun 20 07:53:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212404, encodeId=dc01212404f2, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Sun Jun 18 18:58:52 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212382, encodeId=0aeb21238228, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jun 18 16:59:58 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1989042, encodeId=369a1989042aa, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Fri Apr 06 22:53:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498208, encodeId=69a71498208c3, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jun 20 07:53:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212404, encodeId=dc01212404f2, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Sun Jun 18 18:58:52 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212382, encodeId=0aeb21238228, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jun 18 16:59:58 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1989042, encodeId=369a1989042aa, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Fri Apr 06 22:53:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498208, encodeId=69a71498208c3, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jun 20 07:53:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212404, encodeId=dc01212404f2, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Sun Jun 18 18:58:52 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212382, encodeId=0aeb21238228, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jun 18 16:59:58 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-06-18 tanxingdoctor

    学习啦!谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1989042, encodeId=369a1989042aa, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Fri Apr 06 22:53:00 CST 2018, time=2018-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498208, encodeId=69a71498208c3, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Tue Jun 20 07:53:00 CST 2017, time=2017-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212404, encodeId=dc01212404f2, content=学习啦!谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLK1wzJZRTON4gxYUibhUyOypBwMibC4R7SsppicGhz5Ogoy0VVq4CWnqaD2Moeib8RWxI5lOiaVmnxpan/0, createdBy=c53f1730331, createdName=tanxingdoctor, createdTime=Sun Jun 18 18:58:52 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=212382, encodeId=0aeb21238228, content=学习了,谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Sun Jun 18 16:59:58 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-06-18 1e145228m78(暂无匿称)

    学习了,谢谢作者分享!

    0

相关资讯

JAMA Intern Med:学历越高,心血管病风险越低

近日,美国发布的一项研究显示,对于中年人,不管社会经济地位如何,随着每个人接受的学校教育水平升高,其终生(45-85岁)心血管病风险逐渐降低。

JCEM:哪些心血管疾病的危险因素会影响甲状腺功能?(ARIC研究)

轻度甲状腺功能障碍者(有争议的治疗)和中度或重度甲状腺功能障碍(标准治疗)者的心血管结局仍然是不确定的。6月发表在JCEM上的一项研究横断面和前瞻性的探讨了甲状腺功能与心血管危险因素和事件之间的关系。在社区动脉粥样硬化风险研究(ARIC研究)中,研究人员测量了储存的于1990-1992年收集的血清样本中的促甲状腺激素(TSH)、游离甲状腺素(FT4)、总T3的浓度。研究人员用多变量线性回归评估了甲

J Hypertens:尿调节素与高血压和心血管疾病患者心肾功能的相关性分析!

由此可见,这些研究结果扩展了以前证实的UMOD对肾功能的作用,也对动脉高血压治疗的高危患者有作用,并且揭示了其与左心房重塑之间的一种新的关联,从而揭示了UMOD调节潜在的心肾联系的作用。

Eur J Prev Cardiol:提高心血管疾病患者药物使用的依从性 从转换为聚合片治疗开始

心血管疾病一般需要长期服用药物。所以,探讨更优的药物方案一直是科学家的研究热点。2017年6月,发表在《Eur J Prev Cardiol》的一项由荷兰、爱尔兰、澳大利亚等国科学家进行的研究,考察了将心血管疾病患者不同治疗方案转换为固定剂量组合片的影响。

Eur J Prev Cardiol: 降低心血管疾病风险 体重正常的中老年人也要运动?

2017年6月,发表在《Eur J Prev Cardiol》的由荷兰科学家进行的鹿特丹研究表明,中老年人群中体育活动是比身体质量指数(BMI)影响心血管疾病(CVD)风险更重要的因素。

LANCET DIABETES ENDO:二甲双胍对I型糖尿病和心血管疾病有怎样的作用效果?

二甲双胍可减少I型成年糖尿病患者胰岛素用量,二甲双胍是否对糖尿病患者有其他效果?而对于心血管疾病是否也有疗效呢?